13F
中

LXEO LEXEO THERAPEUTICS INC

2026Q1 · CUSIP 52886X107 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
138
Δ holders QoQ
-8
Breadth percentile
Top 83%
Whale holders
71
Δ whales
-4
Inst. holding value
$458M
New positions
21
Closed positions
29
Price momentum (1Q)
-25.0%
Put / Call
1/3

Breadth history (34 quarters)

2024Q1: Δ+23 · h=55 2024Q2: Δ+5 · h=60 2024Q3: Δ+10 · h=70 2024Q4: Δ+21 · h=91 2025Q1: Δ-2 · h=89 2025Q2: Δ+2 · h=91 2025Q3: Δ+20 · h=111 2025Q4: Δ+35 · h=146 2026Q1: Δ-8 · h=138 2024Q1: holders=55 2024Q2: holders=60 2024Q3: holders=70 2024Q4: holders=91 2025Q1: holders=89 2025Q2: holders=91 2025Q3: holders=111 2025Q4: holders=146 2026Q1: holders=138 -35 -17.5 +0 +17.5 +35 49102154 24Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 15% -25.0% —
2025Q3 Top 16% -33.9% -46.0%
2024Q1 Top 13% -14.2% -52.0%

Options Sentiment

Put holders
1
QoQ: 0
Call holders
3
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.12
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.77 2024-06-30: EPS -0.64 2024-09-30: EPS -0.89 2024-12-31: EPS -0.79 2025-03-31: EPS -0.99 2025-06-30: EPS -0.60 2025-09-30: EPS -0.33 2026-03-31: EPS -0.25 -1.09 -0.54 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)